Author: creative
-
Tribal leaders meet with feds in push against opioid abuse
ALBUQUERQUE, N.M. (AP) — American Indian tribal leaders from northern New Mexico — an area of the country devastated by heroin and opioid addiction — met with the U.S. Justice Department on Tuesday over ways to combat opioid abuse amid high overdose deaths among Native Americans.
-
Egyptian court hands nine policemen jail terms for assaulting doctors
An Egyptian court sentenced nine policemen to three years in prison on Tuesday for physically and verbally assaulting two doctors at a Cairo hospital in January, an incident that prompted strikes and a protest demanding justice. The policemen are not in jail. Momin Abdelazim, one of the two doctors allegedly involved, told Reuters at the…
-
Allergan to buy Tobira in push for fatty liver disease drugs
Just hours later on Tuesday, Allergan announced it would also pay $50 million upfront and make future milestone payments for Akarna Therapeutics Ltd, a privately held company that is planning early-stage studies of a treatment for NASH. There are no approved treatments for the disease affecting more than 15 million Americans, which involves accumulation of…
-
Astrazeneca says Forxiga combination beats use of drug alone
AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own. In a late stage trial, Forxiga and Bydureon were tested on patients whose blood sugar levels could no longer be sufficiently kept in check under an initial…
-
Novo plans larger study after encouraging semaglutide results
By Nikolaj Skydsgaard COPENHAGEN (Reuters) – Novo Nordisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent, according to results released on Friday, paving the way for a new and bigger study on the drug's benefits. Semaglutide is the third diabetes drug to show such heart benefits, after Novo's Victoza injectable and Eli…
-
Japan confronts disability stigma after silence over murder victims’ names
By Kwiyeon Ha and Linda Sieg TOKYO (Reuters) – The stabbing deaths of 19 disabled people in their sleep last July and the silence surrounding their identities are forcing Japan to grapple with its attitudes toward physically and cognitively impaired persons, less than four years before Tokyo hosts the Paralympics. Almost nothing except their genders…
-
Bayer clinches Monsanto with improved $66 billion bid
NEW YORK/FRANKFURT (Reuters) – German drug and crop chemical maker Bayer clinched a $66 billion takeover of U.S. seeds company Monsanto on Wednesday, ending months of wrangling with a third sweetened offer that marks the largest all-cash deal on record. The $128-a-share deal, up from Bayer's previous offer of $127.50 a share, has emerged as…
-
FDA panel recommends dropping serious warning on Pfizer’s Chantix
Pfizer's Chantix was approved about a decade ago, but thousands of reports of mental health problems in users led to the FDA imposing the “black box” warning – the most severe available – in 2009. On Wednesday, four of the 19 panelists voted to update the language in the box warning – of neuropsychiatric risks…